ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last1,321 to 1,340 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Chronic HF Without SDB vs Chronic HF With SDB: Nocturnal Dyspnea672 of 3,686

800 of 3,190

-6.8 points

-8.8 to -4.9

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Patients With Chronic HF Without SDB Male vs Patients With Chronic Heart Failure and SDB Male: Male Gender as Predictor for SDB in Chronic HF2,754 of 3,686

2,674 of 3,190

-9.1 points

-11.0 to -7.2

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Patients With Chronic HF Without SDB and Ischemic Etiology vs Patients With Chronic Heart Failure and SDB and Ischemic Etiol: Ischemic Etiology as Predictor for SDB in Chronic HF1,961 of 3,686

1,742 of 3,190

-1.4 points

-3.8 to 1.0

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Aldosterone Antagonists1,808 of 3,686

1,454 of 3,190

3.5 points

1.1 to 5.8

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Patients With Chronic HF Without SDB and AF vs Patients With Chronic Heart Failure and SDB and AF: Atrial Fibrillation (AF) as a Predictor for SDB in Chronic HF863 of 3,686

1,001 of 3,190

-8.0 points

-10.1 to -5.9

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Beta-blocker3,284 of 3,686

2,824 of 3,190

0.6 points

-0.9 to 2.1

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Atrial Fibrillation863 of 3,686

1,001 of 3,190

-8.0 points

-10.1 to -5.9

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Medication ACE Inhibitors and/ARBs3,269 of 3,686

2,812 of 3,190

0.5 points

-1.0 to 2.1

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Diuretics2,805 of 3,686

2,617 of 3,190

-5.9 points

-7.8 to -4.0

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Male Gender2,754 of 3,686

2,674 of 3,190

-9.1 points

-11.0 to -7.2

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Chronic HF Without SDB vs Chronic HF With SDB: Nocturia ≥3 Times/Night580 of 3,686

660 of 3,190

-5.0 points

-6.8 to -3.1

6,876NCT01500759

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Nesiritide vs Placebo: Composite of Cardiovascular Rehospitalization and Cardiovascular Mortality372 of 3,423

402 of 3,415

-0.9 points

-2.4 to 0.6

6,838NCT00475852

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Nesiritide vs Placebo: Composite of Rehospitalization Due to Heart Failure and All-Cause Mortality321 of 3,423

345 of 3,413

-0.7 points

-2.1 to 0.7

6,836NCT00475852

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Vaccinated vs Unvaccinated: Across Years, Estimate the Difference in Carriage Prevalence of N. Meningitidis Genogroups Causing Disease (A, B, C, W, X, Y) Between South Australian School Leavers Who Received 4CMenB Vaccine and Unvaccinated Students200 of 3,885

159 of 2,909

-0.3 points

-1.4 to 0.7

6,794NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

2018 School Leavers vs 2019 School Leavers: Estimate the Difference in Carriage Prevalence of Disease Associated Genogroups of N. Meningitidis (A, B, C, W, X, Y) Between School Leavers in 2018 (Year 12 in 2017) and 2019 (Year 12 in 2018), Following a 4CMenB School Immunisation Program225 of 4,104

134 of 2,690

0.5 points

-0.6 to 1.6

6,794NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

2018 School Leavers vs 2019 School Leavers: Estimate the Difference in Carriage Prevalence of All N. Meningitidis Genogroups Between South Australian School Leavers in 2018 (Year 12 in 2017) and 2019 (Year 12 in 2018)393 of 4,104

227 of 2,690

1.1 points

-0.3 to 2.5

6,794NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

Vaccinated vs Unvaccinated: Across Years, Estimate the Difference in Carriage Prevalence of All N. Meningitidis Genogroups Between South Australian School Leavers Who Have Received 4CMenB and Unvaccinated Students.339 of 3,885

281 of 2,909

-0.9 points

-2.3 to 0.4

6,794NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

Intensive Glycemic Control vs Standard Glycemic Control: Number of Participants With at Least One Fall1,122 of 3,364

1,133 of 3,418

0.2 points

-2.0 to 2.4

6,782NCT00324350

Intensive Glycemic Control and Skeletal Health Study

Male vs Female: Identify Characteristics Associated With Carriage Prevalence of N. Meningitidis Genogroups Causing Disease (A, B, C, W, X, Y) in South Australian School Leavers in 2018 /2019154 of 2,709

204 of 4,055

0.7 points

-0.4 to 1.8

6,764NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

Male vs Female: Identify Characteristics Associated With Carriage Prevalence of All N. Meningitidis Genogroups in South Australian School Leavers in 2018/2019268 of 2,709

350 of 4,055

1.3 points

-0.1 to 2.7

6,764NCT03419533

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=67

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01500759-2f241d51",
        "title": "Chronic HF Without SDB vs Chronic HF With SDB: Nocturnal Dyspnea",
        "summary": "672 of 3686 against 800 of 3190; risk difference -6.8 points, 95% interval -8.8 to -4.9; NCT01500759, Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry",
        "record": "/library/comparisons/NCT01500759-2f241d51",
        "nct_id": "NCT01500759",
        "kind": "outcome",
        "participants": 6876,
        "risk_difference": {
          "value": -0.06847225033465607,
          "lower": -0.0880262393309323,
          "upper": -0.04895770134317816
        },
        "group_1": "672 of 3,686",
        "group_2": "800 of 3,190",
        "difference": "-6.8 points",
        "interval": "-8.8 to -4.9",
        "trial_title": "Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry"
      },
      {
        "id": "NCT01500759-3d1713cb",
        "title": "Patients With Chronic HF Without SDB Male vs Patients With Chronic Heart Failure and SDB Male: Male Gender as Predictor for SDB in Chronic HF",
        "summary": "2754 of 3686 against 2674 of 3190; risk difference -9.1 points, 95% interval -11.0 to -7.2; NCT01500759, Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry",
        "record": "/library/comparisons/NCT01500759-3d1713cb",
        "nct_id": "NCT01500759",
        "kind": "outcome",
        "participants": 6876,
        "risk_difference": {
          "value": -0.09109313049290968,
          "lower": -0.10998886875480489,
          "upper": -0.07202995764214573
        },
        "group_1": "2,754 of 3,686",
        "group_2": "2,674 of 3,190",
        "difference": "-9.1 points",
        "interval": "-11.0 to -7.2",
        "trial_title": "Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=68",
  "request_id": "zW3gfjjSHDgzNsxO"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?